Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lexaria Bioscience Corp LEXX

Alternate Symbol(s):  LEXXW

Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is engaged in pursuing the enhancement of the bioavailability of a diverse and a range of active pharmaceutical ingredients (API) using DehydraTECH, its patented proprietary drug delivery technology. The Company’s patented drug delivery technology, DehydraTECH, is designed to improve the way active molecules enter the bloodstream upon oral ingestion. DehydraTECH has also demonstrated enhanced delivery of certain active molecules into brain tissue. The Company has also developed DehydraTECH formulations for other applications demonstrating bio-absorption when administered intraorally and topically. It operates through two segments: Intellectual Property and Products. It also operates a licensed in-house research laboratory and holds an intellectual property portfolio with 35 patents granted and many patents pending worldwide. Its subsidiaries include Lexaria CanPharm ULC, and Lexaria CanPharm Holdings Corp.


NDAQ:LEXX - Post by User

Bullboard Posts
Post by Patiencemysonon Sep 23, 2020 5:18pm
165 Views
Post# 31606345

Uplisting and two deals in one month

Uplisting and two deals in one monthThe company is certain they can meet the requirements of the senior exchange and with the news today, They are one step closer.  Will gap on open for sure.  It appears the trend line they are on could achieve overhead resistance at $.80 but the buyers and sellers will give us about 25- 30 % per day so the $.15 tommorow and the $.20 on the next day will get us close.  
I am not sure what valuation on the contract as the CBD being used is either theirs under purchase agreement or it belongs to the company that is reqesting conversion of liquid to powder.  Not much detail in press release.  Further with regard to the British American Tobacco deal.  This is a potential blockbuster.  Not bad for a company that is quietly growing a significant revenue stream.

I bought $ Long and holding for Uplist details.
Bullboard Posts